Superior effect of allopurinol compared to febuxostat on the retardation of chronic kidney disease progression

BACKGROUND: Although hyperuricemia is associated with chronic kidney disease, whether and how it should be managed for renoprotection remains debatable. Thus, we investigated whether allopurinol and febuxostat, the most frequently used urate-lowering treatments, have differential renoprotective effe...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Seokwoo, Lee, Jung Pyo, Kim, Dong Ki, Kim, Yon Su, Lim, Chun Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8884483/
https://www.ncbi.nlm.nih.gov/pubmed/35226683
http://dx.doi.org/10.1371/journal.pone.0264627

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8884483/
https://www.ncbi.nlm.nih.gov/pubmed/35226683
http://dx.doi.org/10.1371/journal.pone.0264627

Ejemplares similares